Titan Biotech Ltd (BSE: 524717) is a New Delhi, Delhi-based company in the Food and Feed Ingredients industry. With a market capitalisation of ₹1,681 Cr, it ranks #1,319 by market cap among the 6,137 Indian listed companies on FinBizNet, and #1 of 2 in Food and Feed Ingredients. At ₹325.85 (as of 25 Oct 2026), the share price is 26.7% below its 52-week high of ₹444.52 and 137.6% above its 52-week low of ₹137.12. The share price is up 57.9% over one year and down 2.1% over three months.
| Current Price | ₹325.85 |
|---|---|
| Market Cap | ₹1,681 Cr |
| BSE Code | 524717 |
| Sector | Materials > Chemicals > Speciality Chemicals |
| Sub-Industry | Specialty Chemicals > Food and Feed Ingredients |
| P/E Ratio | 56.5 |
| Return on Equity | 17.84% |
| Return on Assets | 10.79% |
| 52-Week Range | ₹137.12 – ₹444.52 |
| 1-Year Price Change | +57.9% |
| 3-Month Price Change | -2.1% |
| Beta (1Y) | -0.92 |
| Dividend Yield | 0.12% |
| Headquarters | New Delhi, Delhi |
| Website | titanbiotechltd.com |
| Revenue | ₹59 Cr |
|---|---|
| Net Profit | ₹9 Cr |
| Net Margin | 16.0% |
| EPS (Basic) | ₹2.29 |
| Basis | standalone |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Titan Biotech Limited engages in the manufacture and sale of biological products in India and internationally. It offers food ingredients, including hydrolyzed vegetable protein, yeast extract powder, calcium propionate powder, potassium sorbate, and calcium lactate; collagen and protein products, such as wheat hydrolysate protein, corn hydrolysate protein, bovine collagen peptide, collagen peptide, fish collage, undernatured chicken collagen type II, mucopolysaccharides, chicken protein isolate, soya protein isolate, and pea protein isolate; and brown rice protein, milk protein, protein hydrolysate, bovine cartilage extract, L-glutathione, cow colostrum powder, collagen peptides, whey protein, sodium caseinate, chondroitin sulphate, and hyaluronic acid. The company also provides coenzyme Q10, glucosamine KCL/HCL, methyl sulfonyl methane, chelated minerals, and peptone; OX bile extract, cholic acid, cerebroprotein hydrolysate, and iron protein succinylate; medicinal yeast and brewer ye
1. Biological Goods-This segment engages in the manufacture and distribution of biological products, including biological peptones and extract, and dehydrated culture media.
1. Biological Goods-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Titan Biotech Ltd | ₹1,681 Cr | 56.5 | 17.84% | ₹59 Cr | +57.9% |
| Vidhi Specialty Food Ingredients Ltd | ₹1,659 Cr | 34.3 | 15.57% | ₹146 Cr | -11.5% |
Listed by market capitalisation. Ratios are shown for context only.
Titan Biotech Ltd is trading at ₹325.85, with a market capitalisation of ₹1,681 Cr.
Titan Biotech Ltd operates in the Materials > Chemicals > Speciality Chemicals space (Specialty Chemicals > Food and Feed Ingredients).
Titan Biotech Ltd has a P/E of 56.5 and a return on equity of 17.84%.
Titan Biotech Ltd is listed on the BSE under the scrip code 524717.
Titan Biotech Ltd's share price is up 57.9% over one year and down 2.1% over three months. Its 52-week range is ₹137.12 to ₹444.52.
In Q1 FY27, Titan Biotech Ltd reported revenue of ₹59 Cr and net profit of ₹9 Cr, with basic EPS of ₹2.29 (standalone, parsed from the company's exchange filing).
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.